Company record
Novartis Pharmaceuticals Corporation
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about Novartis Pharmaceuticals Corporation.
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Aug 19 | Class II | Novartis Pharmaceuticals Corporation Drug |
Diovan (valsartan) 160 mg, 90 tablets, Rx only, Manufactured by: Patheon Manufacturing Services LLC, Greenville, NC 27834, Distributed by: Novartis Pharmaceutical Corp, East Hanover, NJ 07936, NDC 0078-0359-34 Failed Dissolution Specifications |